Drug news
Alair Bronchial Thermoplasty System(Boston Scientific) has positive technology assessment
Boston Scientific Corporation announces the first published technology assessment in support of the safety, efficacy and long-term positive health outcomes of bronchial thermoplasty (BT) as delivered by the Alair Bronchial Thermoplasty System, a catheter-based device designed to treat patients 18 years or older with severe persistent asthma. The report was published by the California Technology Assessment Forum (CTAF) and states that BT, when performed in patients with poorly controlled severe persistent asthma, meets its five technology assessment criteria. The Alair Bronchial Thermoplasty System has FDA approval.
530 mins
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.